Use of Low-Dose Recombinant Factor Ⅶa for Uncontrolled Perioperative Bleeding

BACKGROUND: Recombinant activated factor VIIa (rFVIIa) is a prohemostatic agent initially approved for use in hemophilia patients and has also been used for a diverse range of off-label indications in the context of massive uncontrolled blood loss; however, no convincing evidence exists regarding th...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Dose Response
Autors principals: Chang, Zhi-gang, Chu, Xin, Chen, Wen, Hu, Jun-hua, Gong, Ji-wu, Liu, Da-dong, He, Qing, Feng, Zhe, Xiao, Shi-rou, Liu, Ya-lin
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2020
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7686627/
https://ncbi.nlm.nih.gov/pubmed/33281510
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1559325820969569
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars